SD809-HD
Total Payments
$451,805
Transactions
3,947
Doctors
1,580
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $451,805 | 3,947 | 1,580 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $293,260 | 102 | 64.9% |
| Travel and Lodging | $80,502 | 312 | 17.8% |
| Food and Beverage | $78,043 | 3,533 | 17.3% |
Ad
Manufacturing Companies
- Teva Pharmaceuticals USA, Inc. $451,805
Product Information
- Type Drug
- Total Payments $451,805
- Total Doctors 1,580
- Transactions 3,947
About SD809-HD
SD809-HD is a drug associated with $451,805 in payments to 1,580 healthcare providers, recorded across 3,947 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..
Payment data is available from 2017 to 2017. In 2017, $451,805 was paid across 3,947 transactions to 1,580 doctors.
The most common payment nature for SD809-HD is "Consulting Fee" ($293,260, 64.9% of total).